Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (ii) All outpatient clients, ratio of males to females by country and primary drug

Country		Opioids	Cocaine	Stimulants	Hypnotics and sedatives	Hallucinogens	Volatile substances	Cannabis	Other drugs	Gender and drug known
Belgium	(1)	3.9	3.8	2.7	2.3	1.7		6.8	2.5	3250
Bulgaria		4.9		1.4	1.5			2.8		1313
Czech Republic		2.2	5.0	1.3	0.6	4.0	9.0	2.8	0.6	2021
Denmark		3.6	4.3	2.7	1.0		2.0	3.7	1.8	4022
Germany		3.4	6.0	2.9	0.8	3.1	1.1	6.5	3.6	55292
Estonia	(2)	3.5		1.8			0.0			625
Ireland		2.2	6.8	3.2	1.4	3.0	1.1	5.4	2.3	4824
Greece		6.4	5.4	25.0	3.0			6.8		2311
Spain	(3)	5.5	6.1	3.8	1.5	4.9	7.3	5.6	2.4	50402
France		3.6	3.4	3.4	1.6	5.1	2.8	6.5	2.7	32538
Italy	(4)	6.0	6.0	6.0	5.8	6.1		6.0	6.3	53990
Cyprus		5.0	10.2	1.0	0.3			15.4		509
Latvia										0
Lithuania	(5)	4.3	1.0	2.6	1.5		14.8	7.8	4.3	5808
Luxembourg		2.7	2.0	0.8				0.0		240
Hungary		5.8	5.9	3.6	0.7	5.0	3.8	9.0	1.9	1969
Malta	(6)	4.7	7.3	2.2			1.0	8.1		692
Netherlands	(7)	4.8	5.1	3.3	1.0	2.3	1.5	3.8	0.7	10132
Austria		2.4	4.9	2.6	1.6	2.3	1.0	5.6	1.0	3089
Poland										0
Portugal										0
Romania		6.7	6.0	13.0				13.0		437
Slovenia		3.8	8.0	0.0	0.0			4.3		648
Slovakia		2.5	7.0	3.4	0.5		5.0	10.5		703
Finland		2.4	0.5	1.6	2.6			3.6	0.6	1120
Sweden		1.9	7.3	1.5	0.9	8.0	1.0	4.8	2.4	1787
United Kingdom		2.7	3.1	1.7	1.5	2.3	1.7	3.2	2.5	119440
Croatia		5.0	4.9	5.6	1.9		1.0	10.2	12.0	6449
Turkey										0
Norway										0
Total		3.5	4.8	2.2	1.3	3.9	2.8	5.0	3.1	3.8
Total base		190990	66553	14553	6362	1391	835	78950	3977	363611

Notes:

 Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented. 

 (1) Last available data refer to 2005 and to outpatient centres and low-threshold agencies (aggregated data). Brussels Capital Region is not covered. 

 (2) For Cannabis 8 males have been reported 

 (3) Data refer to 2007 and to outpatient and prison centres (aggregated data). 

 (4) For Volatile substances 50 males have been reported                     

 (5) For Hallucinogens 8 males have been reported                     

 (6) Last data available refer to 2006 and to outpatient, inpatient treatment centres, low-threshold agencies, units in prison and dual-diagnosis unit of psychiatric hospital (aggregated data). 

 (7) Data refer to outpatient, inpatient and low-threshold agencies (aggregated data). 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2009 — TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)